{"id":447995,"title":"Notice: Prescription Drug List (PDL): Multiple additions [2018-12-27] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T15:47:11.699000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-2018-12-27.html?wbdisable=false","snippet":"Notice: Prescription Drug List (PDL): Multiple additions - December 27, 2018 December 27, 2018 Our file number: 18-121421-216 The purpose of this Notice of Amendment is to notify about the additions of Pralatrexate, Elagolix, Dinutuximab, Suvorexant, Elvitegravir, Cobicistat and…","rawSnapshotUrl":"/api/snapshots/raw/447995","browseUrl":"https://replay.healtharchive.ca/job-6/20260103154711/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-2018-12-27.html?wbdisable=false#ha_snapshot=447995","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}